Effects of xylazine on the stress response to transport in male goats.
A 20-min van journey increased plasma cortisol concentrations to 15-25 ng/ml in male goats, blood glucose concentrations were not affected, but respiratory rates and heart rates were increased, the latter by 40 beats per min. A 2-h van journey increased plasma cortisol to greater than 25 ng/ml and blood glucose to greater than 5 mmol/l. Respiratory rates were increased to greater than 40 breaths per min and heart rates by greater than 100 beats per min. Xylazine alone (0.01 mg/kg) suppressed resting plasma cortisol concentrations, increased blood glucose concentrations to 4.5 +/- 0.8 mmol/l and suppressed respiratory rates by 5-10 breaths per min and heart rates by 20 beats per min. Cortisol concentrations were suppressed by xylazine treatment if given before a 20-min van journey, and for approximately 60 min if given 20 min after the start of a 2-h journey. When combined with transport, xylazine caused an additive effect on glucose concentrations, but suppressed respiratory and heart rates. However, for the latter criteria the timing of suppression was different depending on the time of onset and duration of the stressor. Injection of 50 micrograms ovine corticotrophin releasing factor (CRF) caused an immediate elevation of cortisol concentrations (but not glucose) which lasted for at least 6 h compared with the return to baseline within 60 min after either length of journey. Xylazine pretreatment did not alter the cortisol response to CRF, suggesting that xylazine must act centrally above pituitary level when blocking the cortisol response to transport. It is proposed that under resting conditions the hypothalamus is under alpha 2-adrenergic suppression. Stimulation of cortisol secretion in response to a stressor can be inhibited by an alpha 2-adrenergic agonist.
Sanhouri
A A
AA
Department of Veterinary Clinical Science, University of Liverpool, Neston, South Wirral.
Jones
R S
RS
Dobson
H
H
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D015511:Goat Diseases / Q000517:prevention & control*; D006041:Goats; D006339:Heart Rate / Q000187:drug effects; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D012119:Respiration / Q000187:drug effects; D013312:Stress, Physiological / Q000517:prevention & control / Q000662:veterinary*; D014186:Transportation; D014991:Xylazine / Q000627:therapeutic use*
D001786:Blood Glucose; D014991:Xylazine; D006854:Hydrocortisone